Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan 15;22(2):298-307.
doi: 10.1002/cbic.202000430. Epub 2020 Sep 11.

Unconventional Biocatalytic Approaches to the Synthesis of Chiral Sulfoxides

Affiliations
Review

Unconventional Biocatalytic Approaches to the Synthesis of Chiral Sulfoxides

Silvia Anselmi et al. Chembiochem. .

Abstract

Sulfoxides are a class of organic compounds that find wide application in medicinal and organic chemistry. Several biocatalytic approaches have been developed to synthesise enantioenriched sulfoxides, mainly by exploiting oxidative enzymes. Recently, the use of reductive enzymes such as Msr and Dms has emerged as a new, alternative method to obtain enantiopure sulfoxides from racemic mixtures. In parallel, novel oxidative approaches, employing nonclassical solvents such as ionic liquids (ILs) and deep eutectic solvents (DESs), have been developed as greener and more sustainable biocatalytic synthetic pathways. This minireview aims highlights the recent advances made in the biocatalytic synthesis of enantioenriched sulfoxides by employing such unconventional approaches.

Keywords: biocatalysis; deep eutectics; ionic liquids; reductive enzymes; sulfoxides.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Natural sulfoxide‐ and sulfoxide‐containing drugs and ligands.
Scheme 1
Scheme 1
Synthesis of sulfoxides by using a whole E. coli cell system overexpressing pmMsrA.
Scheme 2
Scheme 2
Conversions of racemic sulfoxides using the crude pmMsrA‐DTT system.
Scheme 3
Scheme 3
Conversion of racemic sulfoxides by using the crude paMsrA‐DTT system.
Scheme 4
Scheme 4
Conversion of racemic sulfoxides by using a whole E. coli cell system overexpressing akMsrB.
Scheme 5
Scheme 5
Deracemisation of racemic sulfoxides in a biphasic aqueous buffer/decane system by using whole cell MsrA and oxaziridine 13.
Scheme 6
Scheme 6
Selectivity of DmsABC found in different anaerobic bacteria species.
Scheme 7
Scheme 7
Kinetic resolution of alkyl aryl sulfoxides by using DmsABC.
Scheme 8
Scheme 8
Mechanism of the electroenzymatic kinetic resolution of rac18 ac.
Scheme 9
Scheme 9
Chemoenzymatic deracemisation of rac19 by using whole‐cell E. coli DmsABC.
Scheme 10
Scheme 10
GOX‐/Cip‐catalysed enantioselective sulfoxidation of aryl sulfoxides in IL [BMIM]PF6.
Scheme 11
Scheme 11
CPO‐catalysed sulfoxidation of methyl phenyl sulfide 23 in ILs.
Scheme 12
Scheme 12
Asymmetric sulfoxidations with P450pyr in a KP Buffer/IL system.
Scheme 13
Scheme 13
Synthesis of (R)‐modafinil 29 by using CPO from C. fumago in a biphasic aqueous buffer/IL.
Scheme 14
Scheme 14
Bienzymatic sulfoxidation of 30 by using AnChOx and rAaeUPO.

References

    1. None
    1. Pellissier H., Tetrahedron 2006, 62, 5559–5601;
    1. Fernández I., Khiar N., Chem. Rev. 2003, 103, 3651–3706; - PubMed
    1. Carreño M. C., Chem. Rev. 1995, 95, 1717–1760.
    1. Martins N., Petropoulos S., Ferreira I. C., Food Chem. 2016, 211, 41–50. - PubMed

Publication types

LinkOut - more resources